TCI Wealth Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

TCI Wealth Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-47	Closed	-$1K	–	1608
2018 Q4	$1K	Hold	47	–	–	﹤0.01%	1383
2018 Q3	$1K	Hold	47	–	–	﹤0.01%	1413
2018 Q2	$1K	Hold	47	–	–	﹤0.01%	1447
2018 Q1	$1K	Buy	+47	New	+$795	﹤0.01%	1294
2017 Q4	–	Sell	-49	Closed	-$1K	–	1453
2017 Q3	$1K	Buy	+49	New	+$913	﹤0.01%	1260
2017 Q2	–	Sell	-27	Closed	-$1K	–	1400
2017 Q1	$1K	Buy	+27	New	+$646	﹤0.01%	1225
2016 Q2	–	Sell	-29	Closed	-$1K	–	1420
2016 Q1	$1K	Buy	+29	New	+$688	﹤0.01%	1217

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCI Wealth Advisors's AMAG Position: Q1 2019 in Review

TCI Wealth Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 47 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in AMAG in Q1 2016 and held it in 7 quarters. The position peaked at $1K in Q4 2018. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

TCI Wealth Advisors reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
TCI Wealth Advisors sold 47 AMAG Pharmaceuticals shares in Q1 2019, an estimated $1K.
TCI Wealth Advisors first reported a position in AMAG Pharmaceuticals in Q1 2016 and held it in 7 quarters.
TCI Wealth Advisors's AMAG Pharmaceuticals position peaked at $1K in Q4 2018.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on TCI Wealth Advisors's 13F filing for Q1 2019, filed 11 Apr 2019.